
Molly® 2.25
A large volume variation of the classic Molly® auto-injector, the Molly® 2.25 is designed to accommodate fill volumes up to 2.25mL.
SHL is a world-leading solution provider in design, development, and manufacturing of advanced drug delivery systems.
SHL is a world-leading solution provider in design, development, and manufacturing of advanced drug delivery systems.
We also offer core competencies and services in the fields of Medtech and patient care solutions.
We work with leading biotechnology and pharmaceutical companies to develop drug delivery devices, including compact disposable auto-injectors, reusable pen injectors, and complex inhaler systems.
These devices use standard pre-filled syringes and cartridges, as well as novel primary containers.
SHL has always invested significantly in research and development. The investment has especially intensified over the past ten years, allowing us to upgrade our broad pipeline of next-generation drug delivery devices.
These innovative devices include advanced reusable and disposable injectors that can be enhanced through digital implementations and can accommodate high volume and high viscosities. Our investments have strengthened our support in the advancement of drug development and digital healthcare.
SHL, as a renowned, high-quality, high-volume manufacturer, is ranked among the top global producers of drug delivery devices. Central to our success is the vertical integration of key manufacturing capabilities to ensure quality and time-to-market.
Developing drug delivery devices in-house allows us to customize existing platforms in our pipeline or develop completely new bespoke devices based on the unique requirements for our clients.
SHL provides final assembly, labelling and packaging services of drug delivery devices to the pharmaceutical and biotechnology industries.
These services were established to streamline the production and distribution process for our injection products so as to bring improved end-product quality and faster time-to-market to our clients across the globe.
By integrating an additional piece of the supply chain, we offer a fully comprehensive experience for our customer’s drug delivery products.
SHL’s international team of dedicated professionals work round the clock to ensure that customer expectations are met and final products are delivered at optimum quality and speed. We provide a comprehensive range of services to meet our client’s project requirements:
With locations in Taiwan, Sweden, Switzerland, and the US, and a global staff of more than 5,000 employees, our experienced engineers and designers develop product enhancements and breakthrough drug delivery solutions for clients globally.
As SHL is determined to provide the most comprehensive range of solutions and services, we maintain all key capabilities and processes in-house to ensure the best quality and time-to-market.
A large volume variation of the classic Molly® auto-injector, the Molly® 2.25 is designed to accommodate fill volumes up to 2.25mL.
An ultra-compact auto-injector that is ideal for convenience and portability.
A highly versatile auto-injector that can accommodate a wide range of fill volumes and liquid viscosities.
A constant-force technology that allows the delivery of highly viscous formulations of up to several hundred centipoise.
A multi-use injector with a 2.25mL glass syringe that is reusable up to 200 times.
A safety syringe designed with an automatic needle guard that allows the needle to be permanently hidden throughout the injection process.
A dual-chamber auto-injector paired with SHL's NIT® (Needle Isolation Technology) and a simple Twist & Mix mechanism.
A cartridge-based auto-injector built with SHL's market-proven NIT® (Needle Isolation Technology), the VSDI® + NIT® is compatible with cartridge volumes from 1.5mL to 3mL.
A cartridge-based solution built with SHL's market-proven Needle Isolation Technology (NIT®).
An adjustable, multi-dose pen injector with a 3mL cartridge. The device includes an advanced reset feature as well as a dial-back dose correction.
Despite being founded in an age when medical devices were more about getting the job done than providing optimum patient experience, SHL Group has from the very beginning placed emphasis on users and usability.
SHL has extensive experience in the parenteral arena. In this article, SHL details its latest offerings in the world of biologics, as well as its partnership with speciality digital healthcare start-up QuiO to develop injectables in the connected healthcare space.
SHL Medical’s new facility in North Charleston, South Carolina, is expected to start operations by Q2 2024.
SHL Medical (hereinafter referred to as 'SHL') has revealed plans for a new manufacturing site in the US, in response to growing market demand for its autoinjector product portfolio. The decision stems from SHL's strategic assessments in extending its production to North America.
22 July 2022On June 22, SHL Medical’s Chief Operating Officer Martin Turvill will be joined by Helbling Business Advisors Partner and Executive Board Member Sébastien Martin in a Quality and Manufacturing Innovation webinar, hosted by the CPhI Podcast Series.
6 June 2022SHL Medical has announced a donation of US$100,000 to help India combat the unprecedented surge of coronavirus infections and support vulnerable communities affected by the pandemic.
11 June 2021SHL will join the 2020 Parenteral Drug Association’s annual Universe of Pre-Filled Syringes and Injection Devices virtual event with the launch of our virtual experience platform.
17 September 2020SHL Medical, a pioneer and technology frontrunner in the self-injection industry, announced its acquisition of Weibel CDS, a medical technology company offering products and solutions for drug delivery and novel packaging.
30 March 2020SHL will exhibit at Pharmapack Europe 2020 between 5-6 February in Paris, France.
15 January 2020On 5 November, SHL Group held the inauguration of its new Liufu site in Taoyuan City, Taiwan.
15 November 2019SHL will proudly make its first appearance at the 2019 Partnership Opportunities in Drug Delivery (PODD) Conference on 7-8 October, showcasing at Booth 24, the Renaissance Boston Waterfront Hotel in Boston.
23 September 2019SHL will exhibit at the 2019 Contracting and Outsourcing Conference & Tabletop Exhibition on 26 September in New Brunswick, New Jersey. For this two-day conference, the company is set to showcase its quality offerings in final assembly, labelling and packaging at the one-day tabletop exhibition.
23 September 2019SHL Group is exhibiting at the 2019 BIO International Convention in Philadelphia, Pennsylvania, US.
14 May 2019SHL is primed to exhibit at the Prefilled Syringe Seminar in Tokyo.
2 May 2019SHL Group will lead a webinar titled ‘Personalization of Patient Care – The Next Frontier in Drug Delivery’.
22 March 2019SHL Group has announced that it will make its first appearance at the 21st Asia Pacific League of Associations for Rheumatology Congress.
18 March 2019SHL Group is looking forward to exhibiting at the 2019 Pharmapack, Europe's dedicated pharmaceutical packaging and drug delivery event from 6-7 February in Paris, France.
14 January 2019SHL is set to present its market-leading auto-injector offerings and expertise in final assembly and packaging services at the Drug Delivery Partnerships (DDP) conference this year.
7 January 2019SHL Group will take part in the Universe of Pre-Filled Syringes and Injection Devices conference, which is Parenteral Drug Association’s largest event this year and will take place in October.
28 August 2018SHL Group has announced it will be participating in the BIO International Convention in Boston, Massachusetts, US.
8 May 2018SHL Group has announced it will be exhibiting at the Prefilled Syringe Seminar 2018 in Tokyo.
17 April 2018SHL Group has announced it will hold a live webinar to discuss how pharmaceutical companies can leverage a preconfigured device technology to bring their innovative drug formulations to market more efficiently.
5 March 2018SHL has announced it is exhibiting at the 2018 Drug Delivery Partnerships (DDP) conference in Florida.
5 January 2018Thank you for submitting the form. Your enquiry will be submitted to the company.
Thank you for subscribing to Pharmaceutical Technology